Perron Institute of Neurological and Translational Sciences

Organization profile

Organisation profile

The Perron Institute for Neurological and Translational Science (formerly the Western Australian Neuroscience Research Institute – WANRI) is Western Australia’s longest established medical research institute. One of our special strengths is the depth of links between the institute’s laboratory research and its 15 specialist clinics. We undertake cutting edge research on a broad spectrum of conditions including stroke, Parkinson’s, muscular dystrophy and multiple sclerosis. This multidisciplinary approach enables us to translate research outcomes into treatments aimed at providing a better quality of life for millions of people around the world who suffer with devastating neurological conditions.

The Institute is affiliated with The University of Western Australia's Centre for Neuromuscular and Neurological Disorders.  The Centre's research publications are available in this repository via a search by Centre name.

 

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Middle Cerebral Artery Infarction Medicine & Life Sciences
Arginine Medicine & Life Sciences
Peptides Medicine & Life Sciences
Stroke Medicine & Life Sciences
Multiple Sclerosis Medicine & Life Sciences
Neuroprotective Agents Medicine & Life Sciences
Long Noncoding RNA Medicine & Life Sciences
Cladribine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2013 2018

  • 13 Article
  • 2 Abstract/Meeting Abstract
  • 2 Letter
  • 2 Review article
4 Citations

Design of a framework for the deployment of collaborative independent rare disease-centric registries: Gaucher disease registry model

Bellgard, M. I., Napier, K. R., Bittles, A. H., Szer, J., Fletcher, S., Zeps, N., Hunter, A. A. & Goldblatt, J., Feb 2018, In : Blood Cells, Molecules, and Diseases. 68, p. 232-238

Research output: Contribution to journalArticle

Open Access
Gaucher Disease
Rare Diseases
Registries
Orphan Drug Production
Conservation of Natural Resources
9 Citations
Cyclic Peptides
Protamines
Middle Cerebral Artery Infarction
Neuroprotective Agents
Tryptophan
2 Citations

Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis

MSBase Study Group, 31 Aug 2017, In : Multiple Sclerosis.

Research output: Contribution to journalArticle

Cladribine
Interferon-beta
Multiple Sclerosis
Interferons
Recurrence